Abstract
Background: Patients undergoing transcatheter edge‐to‐edge mitral valve repair (TEER) carry a high risk of rehospitalization due to disease, procedure, patient, hospital, and system related factors.Aims: We aimed to explore the impact of gender on in‐hospital mortality and 90‐day readmissions in patients undergoing TEER.Methods: We utilized the National Readmission Database from 2012 to 2018 to identify individuals who underwent TEER for mitral regurgitation. Gender‐based differences in in‐hospital mortality and 90‐day readmissions were explored using multivariable logistic regression models.Results: Between 2012 and 2018, an estimated 21,415 TEER procedural hospitalizations were identified, of which 9893 (46.2%) were in women and 11,522 (53.8%) were in men. Compared with men, women were older, from a lower socioeconomic status but had a lower co‐morbidity burden. In‐hospital mortality rate during the index hospitalization was similar in women and men (2.1% vs. 2.1%, p = 0.908). Ninety‐day all‐cause and heart failure readmission rates were significantly higher in women compared to men (30.2% vs. 25.4%; p < 0.001 and 28.1% vs. 23.9%; p = 0.020 respectively). In a multivariable analysis, women had 36% greater odds of 90‐day readmission compared to men (adjusted odds ratio [aOR] 1.36, 95% CI: 1.22–1.52; p < 0.001). Trend analysis revealed no significant improvement in rates of 90‐day readmission during the observation period for men or women (p = 0.245, p = 0.429, respectively).Conclusions: Following TEER, there has been no significant improvement in 90‐day readmission rates between 2012 and 2018. Female gender is associated with higher 90‐day all‐cause and heart failure readmission rates.

This publication has 26 references indexed in Scilit: